{"id":"https://openalex.org/W4240888652","doi":"https://doi.org/10.17925/ohr.2011.07.2.143","title":"Treatment Options for Myelodysplastic Syndromes","display_name":"Treatment Options for Myelodysplastic Syndromes","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W4240888652","doi":"https://doi.org/10.17925/ohr.2011.07.2.143"},"language":"en","primary_location":{"id":"doi:10.17925/ohr.2011.07.2.143","doi":"https://doi.org/10.17925/ohr.2011.07.2.143","is_oa":false,"landing_page_url":"https://doi.org/10.17925/ohr.2011.07.2.143","pdf_url":null,"source":{"id":"https://openalex.org/S4210173581","display_name":"touchREVIEWS in Oncology & Haematology","issn_l":"2052-3815","issn":["2052-3815","2052-3823","2752-5481"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4404675657","host_organization_name":"Touch Medical Media","host_organization_lineage":["https://openalex.org/P4404675657"],"host_organization_lineage_names":["Touch Medical Media"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology & Hematology Review (US)","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109414891","display_name":"Hillary Prescott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hillary Prescott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049385583","display_name":"Elias Joseph Jabbour","orcid":"https://orcid.org/0000-0003-4465-6119","observed_orcids":["https://orcid.org/0000-0003-4465-6119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elias Jabbour","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jeffrey Bryan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey Bryan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hagop Kantarjian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Assistant Professor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Assistant Professor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"07","issue":"02","first_page":"143","last_page":"143"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":1.0},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":1.0},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-disorders","display_name":"hematopoietic stem cell disorders","score":0.9010000228881836},{"id":"https://openalex.org/keywords/cytopenia","display_name":"cytopenia","score":0.7179999947547913},{"id":"https://openalex.org/keywords/supportive-care","display_name":"supportive care","score":0.8029999732971191},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5630000233650208},{"id":"https://openalex.org/keywords/survival-outcomes","display_name":"survival outcomes","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.9672889709472656},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.9478352069854736},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.9081343412399292},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8371151685714722},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.8267885446548462},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46221014857292175},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37679845094680786},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3310732841491699},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.09804239869117737},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.09749013185501099},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.17925/ohr.2011.07.2.143","doi":"https://doi.org/10.17925/ohr.2011.07.2.143","is_oa":false,"landing_page_url":"https://doi.org/10.17925/ohr.2011.07.2.143","pdf_url":null,"source":{"id":"https://openalex.org/S4210173581","display_name":"touchREVIEWS in Oncology & Haematology","issn_l":"2052-3815","issn":["2052-3815","2052-3823","2752-5481"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4404675657","host_organization_name":"Touch Medical Media","host_organization_lineage":["https://openalex.org/P4404675657"],"host_organization_lineage_names":["Touch Medical Media"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology & Hematology Review (US)","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W81350497","https://openalex.org/W2348621912","https://openalex.org/W2160452578","https://openalex.org/W1967486797","https://openalex.org/W2087211634","https://openalex.org/W2354211702","https://openalex.org/W4231981436","https://openalex.org/W2124819529","https://openalex.org/W2039901186","https://openalex.org/W278144882"],"abstract_inverted_index":{"Myelodysplastic":[0],"syndromes":[1],"(MDS)":[2],"are":[3,92],"a":[4,18,74],"group":[5],"of":[6,20,29,33,43],"heterogeneous":[7],"hematopoietic":[8],"stem":[9],"cell":[10],"disorders":[11],"characterized":[12],"by":[13],"peripheral":[14],"blood":[15],"cytopenias":[16],"and":[17,51,84,90],"risk":[19],"transformation":[21],"to":[22,98],"acute":[23],"myeloid":[24],"leukaemia.":[25],"Until":[26],"recently,":[27],"treatment":[28,42],"MDS":[30,44],"predominately":[31],"consisted":[32],"supportive":[34],"care":[35],"measures.":[36],"However,":[37],"three":[38],"agents":[39,54,83],"for":[40,60],"the":[41,58,68],"have":[45,55],"recently":[46],"been":[47],"approved:":[48],"lenalidomide,":[49,88],"decitabine,":[50],"azacitidine.":[52],"These":[53],"dramatically":[56],"improved":[57],"outcomes":[59],"patients":[61],"with":[62,79],"MDS.":[63],"To":[64],"date,":[65],"azacitidine":[66,91],"is":[67],"only":[69],"agent":[70],"that":[71],"has":[72],"demonstrated":[73],"survival":[75],"advantage":[76],"when":[77],"compared":[78],"conventional":[80],"care.":[81],"Novel":[82],"combination":[85],"regimens":[86],"including":[87],"decitabine":[89],"being":[93],"explored":[94],"in":[95],"an":[96],"effort":[97],"further":[99],"improve":[100],"patient":[101],"outcomes.":[102]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2022-05-12T00:00:00"}